Dahring Cusmano’s Amgen AMGN Stock Holding History

Dahring Cusmano’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,300	Closed	-$921K	–	55
2025 Q2	$921K	Hold	3,300	–	–	0.72%	20
2025 Q1	$1.03M	Sell	3,300 -3	-0.1%	-$886	0.89%	19
2024 Q4	$861K	Buy	+3,303	New	+$980K	0.78%	19

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dahring Cusmano's AMGN Position: Q3 2025 in Review

Dahring Cusmano sold out of Amgen (AMGN) in Q3 2025, closing a stake of 3,300 shares — an estimated $921K sold.

Dahring Cusmano first reported a position in AMGN in Q4 2024 and held it in 3 quarters. The position peaked at $1.03M in Q1 2025. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

Dahring Cusmano reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
Dahring Cusmano sold 3,300 Amgen shares in Q3 2025, an estimated $921K.
Dahring Cusmano first reported a position in Amgen in Q4 2024 and held it in 3 quarters.
Dahring Cusmano's Amgen position peaked at $1.03M in Q1 2025.
2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Dahring Cusmano's 13F filing for Q3 2025, filed 7 Nov 2025.